Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2008
12/04/2008WO2008145705A1 Butenedioic acid or derivatives thereof for treating a biological sample
12/04/2008WO2008145675A2 Transgenic plants with increased stress tolerance and yield
12/04/2008WO2008145629A2 Yield enhancement in plants by modulation of maize alfins
12/04/2008WO2008145603A2 Pharmaceutical compositions comprising telomerase, and uses thereof
12/04/2008WO2008145587A1 Method for purifying cells, recovering cells, and transfecting cells gently
12/04/2008WO2008145406A1 Novel genes encoding insecticidal proteins
12/04/2008WO2008145401A2 Mutated parvovirus structural proteins as vaccines
12/04/2008WO2008145400A2 Mutated structural protein of a parvovirus
12/04/2008WO2008145301A1 Fluorescent proteins and methods of use thereof
12/04/2008WO2008145140A2 Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals
12/04/2008WO2008145133A2 Method for manufacturing a recombinant polyclonal protein
12/04/2008WO2008145084A2 Method and immune absorbents for the specific detection and absorption of celiac disease- and herpetiform dermatitis-associated antibodies
12/04/2008WO2008145021A1 A truncated l1 protein of human papillomavirus 6
12/04/2008WO2008145020A1 A truncated l1 protein of human papillomavirus 11
12/04/2008WO2008145013A1 Fusion protein comprising targeting peptide of cd13 and lidamycin
12/04/2008WO2008145000A1 A foot-and-mouth disease virus double-effective vaccine vector, construction method and uses thereof
12/04/2008WO2008144940A1 Biomarker for hypertriglyceridemia
12/04/2008WO2008144912A1 Antifolate agent-resistant dihydrofolate reductases
12/04/2008WO2008144900A1 A method of enhancing recombinant protein production
12/04/2008WO2008144817A1 Fluorescent protein particles
12/04/2008WO2008118970A9 Constructs and libraries comprising antibody surrogate light chain sequences
12/04/2008WO2008118936A3 Method of elicting immune response with a modified mva viral hiv-1 vector
12/04/2008WO2008111661A3 Method of expression of foreign gene in plant induced by chemical substance
12/04/2008WO2008109511B1 Nucleic acid compounds for inhibiting fcer2 gene expression and uses thereof
12/04/2008WO2008109470A3 Nucleic acid compounds for inhibiting ptpn1 gene expression and uses thereof
12/04/2008WO2008109468B1 Nucleic acid compounds for inhibiting mmp gene expression and uses thereof
12/04/2008WO2008109369A3 Nucleic acid compounds for inhibiting tnf gene expression and uses thereof
12/04/2008WO2008109355B1 Nucleic acid compounds for inhibiting srd5a2 gene expression and uses thereof
12/04/2008WO2008109352A3 Nucleic acid compounds for inhibiting akt gene expression and uses thereof
12/04/2008WO2008103819A3 Chimeric newcastle disease virus vlps
12/04/2008WO2008103380A3 Hepatitis b virus compositions and methods of use
12/04/2008WO2008098227A3 Biofuel production by recombinant microorganisms
12/04/2008WO2008098181A3 In vivo genome-wide mutagenesis
12/04/2008WO2008098148A3 Water deficit-inducible promoters
12/04/2008WO2008097328A9 Asymmetric functionalized nanoparticles and methods of use
12/04/2008WO2008091284A3 Vectors for inducing homozygous mutations and methods of using same
12/04/2008WO2008088839A3 Methods of isolating and purifying nucleic acid-binding biomolecules and compositions including same
12/04/2008WO2008086813A3 Peptides derived from proteins of the insulin super-family
12/04/2008WO2008073893A3 Methods for producing an adenovirus type 5 gene transfer vector
12/04/2008WO2008073578A3 Plant genes involved in nitrate uptake and metabolism
12/04/2008WO2008073154A3 Methods and compositions for treating disease
12/04/2008WO2008070273A3 Methods of expressing lim mineralization protein
12/04/2008WO2008069964A3 Altering regulation of maize lignin biosynthesis enzymes via rnai technology
12/04/2008WO2008067464A3 NEW Aβ CONFORMER SELECTIVE ANTI-Aβ GLOBULOMER MONOCLONAL ANTIBODIES
12/04/2008WO2008067382A3 Rnai-mediated inhibition of aquaporin 4 for treatment of iop-related conditions
12/04/2008WO2008067373A3 RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
12/04/2008WO2008067338A3 Biosynthetic pathway and genes required for tropodithietic acid biosynthesis in silicibacter tm1040
12/04/2008WO2008066658A3 Engineered cellular pathways for programmed autoregulation of differentiation
12/04/2008WO2008054595A3 Drug controlled molecular tags
12/04/2008WO2008036825A3 Duplex oligonucleotide complexes and methods for gene silencing by rna interference
12/04/2008WO2008036675A3 Compositions and methods of enhancing immune responses
12/04/2008WO2008030614A3 Suppressor trna transcription in vertebrate cells
12/04/2008WO2008029276A3 Compositions and methods for the treatment of ophthalmic disease
12/04/2008WO2008028146A3 Novel protein compositions and systems for expression of desaturases
12/04/2008WO2008021149A3 Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna
12/04/2008WO2008008467A3 Metabolic engineering of lipid metabolism by improving fatty acid binding and transport
12/04/2008WO2008008396A3 Dna encoding ring zine-finger protein and the use of the dna in vectors and bacteria and in plants
12/04/2008WO2008005769A3 Methods of inhibiting hcv replication
12/04/2008WO2008005063A3 Enabling methods to identify allosteric modulators of receptor activity
12/04/2008WO2007143571A3 Agrobacterium transformation of guar
12/04/2008WO2007133558A3 Robust expression of a bioactive mammalian protein in chlamydomonas chloroplast
12/04/2008WO2007130403A3 REGULATION OF ApoB BY Hspl 10 PROTEINS AND RELATED COMPOSITIONS AND METHODS
12/04/2008WO2007127882A3 An isolated dna fragment of the human a33 promoter and its use to control the expression of a heterologous gene in tumor cells
12/04/2008WO2007126805A3 Cancer immunotherapy compositions and methods of use
12/04/2008WO2007121467A3 Compositions and methods for increasing transgene expression in the plastids of higher plants
12/04/2008WO2007110623A3 Screening method
12/04/2008WO2007106728A3 Soybean seed and oil compositions and methods of making same
12/04/2008WO2007103532A3 Normalizing cell assay data for models
12/04/2008WO2007100821A3 Piggybac constructs in vertebrates
12/04/2008WO2007089862A3 Alpha-synuclein kinase
12/04/2008WO2006096269A3 Targeted gene deletions for polysaccharide slime formers
12/04/2008WO2006076423A3 Genes and uses for plant improvement
12/04/2008WO2006073625A3 Inhibition of li expression in mammalian cells
12/04/2008US20080301844 Maize plant having increased seed yield through recessive genetic determinants that confer expanded corn ear tips
12/04/2008US20080301842 expression results in production of altered levels of the RNA-directed RNA polymerase in a transformed host cell; vectors, transgenic plants; use as tool to control gene expression via cosuppression and to engineer plant virus resistance
12/04/2008US20080301841 Plants with improved yield and stress tolerance
12/04/2008US20080301840 Conferring biotic and abiotic stress tolerance in plants
12/04/2008US20080301839 Transgenic plants with enhanced agronomic traits
12/04/2008US20080301838 Nucleic acid molecules and other molecules associated with plants
12/04/2008US20080301837 Promoter-based gene silencing
12/04/2008US20080301836 Selection of transcription factor variants
12/04/2008US20080301835 Protein Kinase Stress-Related Polypeptides and Methods of Use in Plants
12/04/2008US20080301834 Plastid Transformation System to Prevent the Intramolecular Recombination of Transgene
12/04/2008US20080301833 Regulatory sequence
12/04/2008US20080301832 Method for Screening Genomic Dna Fragments
12/04/2008US20080301827 Transgenic animal model of neurodegenerative disorders
12/04/2008US20080301826 Novel beta-actin and rps21 promoters and uses thereof
12/04/2008US20080301825 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
12/04/2008US20080301824 Parkin interacting polypeptides and methods of use
12/04/2008US20080301823 Polynucleotide for Producing Recombinant Protein in Silkworm
12/04/2008US20080301822 Role of alpha1-adrenergic receptors
12/04/2008US20080300396 lSOLATION OF NUCLEIC ACID
12/04/2008US20080300395 Using RNA interference to treat and prevent diabetes, alzheimer's, cancer disorders; antisense agents
12/04/2008US20080300384 T-bet compositions and methods of use thereof
12/04/2008US20080300212 Treatment and prevention of hyperproliferative conditions in humans and antisense oligonucleotide inhibition of human replication-initiation proteins
12/04/2008US20080300211 Microrna inhibition for the treatment of inflammation and myeloproliferative disorders
12/04/2008US20080300210 Method of Controlling Insects and Virus Transmission
12/04/2008US20080300209 Gene expression and pain
12/04/2008US20080300208 Isociatrate dehydrogenase and uses therof
12/04/2008US20080300207 Protein production
1 ... 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 ... 4023